Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene 30 (HMGN1P30) is a human pseudogene on chromosome 18 that is closely related in sequence to the functional HMGN1 gene. Pseudogenes like HMGN1P30 lack the ability to produce functional protein products and are considered nonfunctional remnants of gene duplication or mutation events. Unlike their parent protein-coding genes, pseudogenes do not serve as therapeutic targets and typically do not play direct roles in cellular function, signal transduction, or disease pathology, unless future research uncovers rare regulatory functions[1][2][4][7]. In summary, HMGN1P30 is a nonfunctional pseudogene and not a recognized therapeutic target. There is nothing to suggest a protein product, drug interactions, mechanisms of action, biomarker use, or safety issues relevant to drug development for this locus.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 30 (HMGN1P30).